Search:
Browse
Collection All
bullet
bullet
bullet
bullet
bullet
Listed communities
bullet
bullet
HSE
bullet
bullet
LIS
bullet
bullet
bullet

Irish Health Repository > Hospital Research > Leinster > St. Luke's Hospital > Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center.


Files in This Item:

There are no files associated with this item.



Title: Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center.
Authors: Reynolds, John V
Donohoe, Claire L
McGillycuddy, Erin
Ravi, Naraymasamy
O'Toole, Dermot
O'Byrne, Ken
Hollywood, Donal
Affiliation: Department of Surgery, St James's Hospital and Trinity College, Dublin, Ireland. reynoljv@tcd.ie
Citation: Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center. 2012, 143 (5):1130-1137.e1 J. Thorac. Cardiovasc. Surg.
Publisher: Elsevier
Journal: The Journal of thoracic and cardiovascular surgery
Issue Date: May-2012
URI: http://hdl.handle.net/10147/243783
DOI: 10.1016/j.jtcvs.2011.12.003
PubMed ID: 22244551
Abstract: Modern series from high-volume esophageal centers report an approximate 40% 5-year survival in patients treated with curative intent and postoperative mortality rates of less than 4%. An objective analysis of factors that underpin current benchmarks within high-volume centers has not been performed.
Language: en
Keywords: Carcinoma, Squamous Cell/therapy
Esophageal Neoplasms/therapy
Esophagogastric Junction/surgery
Adenocarcinoma/therapy
MeSH: Adenocarcinoma
Age Factors
Carcinoma, Squamous Cell
Chemoradiotherapy, Adjuvant
Chi-Square Distribution
Disease-Free Survival
Esophageal Neoplasms
Esophagectomy
Esophagogastric Junction
Gastrectomy
Hospital Mortality
Hospitals
Humans
Ireland
Kaplan-Meier Estimate
Lymph Node Excision
Multivariate Analysis
Neoadjuvant Therapy
Neoplasm Invasiveness
Neoplasm Staging
Proportional Hazards Models
Prospective Studies
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
ISSN: 1097-685X
Appears in Collections: St. Luke's Hospital

Please use this identifier to cite or link to this item: http://hdl.handle.net/10147/243783
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!



Related articles on PubMed
bullet
The impact of young age on outcomes in esophageal and junctional cancer.
Donohoe CL, MacGillycuddy E, Reynolds JV
2011 Nov
bullet
Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
Schneider PM, Baldus SE, Metzger R, Kocher M, Bongartz R, Bollschweiler E, Schaefer H, Thiele J, Dienes HP, Mueller RP, Hoelscher AH
2005 Nov
bullet
Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
Stiles BM, Mirza F, Coppolino A, Port JL, Lee PC, Paul S, Altorki NK
2011 Aug
bullet
bullet
See all 141 articles

All Items in LENUS are protected by copyright, with all rights reserved, unless otherwise indicated.